Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of SGLT-2 Inhibition on Sympathetic Nervous System Activity in Humans

NCT03912909 is registered in ClinicalTrials.gov with Royal Perth Hospital as lead sponsor.

NCT NCT03912909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03912909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of SGLT-2 Inhibition on Sympathetic Nervous System Activity in Humans
Lead sponsor
Royal Perth Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
August 1, 2018
Completion date
December 30, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome, obesity, type 2 diabetes mellitus